<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33796959</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6776</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Biotechnology letters</Title><ISOAbbreviation>Biotechnol Lett</ISOAbbreviation></Journal><ArticleTitle>MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway.</ArticleTitle><Pagination><StartPage>1357</StartPage><EndPage>1369</EndPage><MedlinePgn>1357-1369</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10529-021-03115-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus71 (EV71), the major cause of hand, foot, and-mouth disease (HFMD), has increasingly become a public health challenge. Type I interferons (IFNs) can regulate innate and adaptive immune responses to pathogens. MicroRNAs (miRNAs) play regulatory roles in host innate immune responses to viral infections. However, the roles of miR-103 and miR-107 in EV71 infection remain unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to determine the expression of miR-103, miR-107, suppressor of cytokine signaling 3 (SOCS3), VP1, IFN-&#x3b1;, and IFN-&#x3b2;. Virus titers were measured by 50% tissue culture infectious dose (TCID<sub>50</sub>) assay. Western blot assay was conducted to detect the protein levels of VP1, IFN-&#x3b1;, IFN-&#x3b2;, SOCS3, signal transducer and activator of transcription 3 (STAT3), and phospho-STAT3 (p-STAT3). Immunofluorescence assay was used to detect the protein level of VP1. The concentrations of IFN-&#x3b1; and IFN-&#x3b2; were examined by Enzyme-linked immunosorbent assay (ELISA). The interaction between SOCS3 and miR-103/miR-107 was predicted by starBase and verified by dual-luciferase reporter assay and RNA pull-down assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">MiR-103 and miR-107 were downregulated and SOCS3 was upregulated in serum from patients with EV71 and EV71-infected cells. Overexpression of miR-103 and miR-107 repressed EV71 replication by inhibiting EV71 titers and VP1 expression. Moreover, upregulation of miR-103 and miR-107 enhanced EV71-triggered the production of type I IFNs. In addition, miR-103 and miR-107 directly targeted SOCS3, and SOCS3 upregulation reversed the effects of miR-103 and miR-107 on EV71 replication and type I IFN response. Importantly, miR-103 and miR-107 increased STAT3 phosphorylation by targeting SOCS3 after EV71 infection.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MiR-103 and miR-107 suppressed EV71 replication and increased the production of type I IFNs by regulating SOCS3/STAT3 pathway, which might provide a novel strategy for developing effective antiviral therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Baizhi</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8014-3882</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Binhaiwan Central Hospital of Dongguan, Dongguan, China. hang1193@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Binhaiwan Central Hospital of Dongguan, No. 111 Humen Avenue, Humen Town, Dongguan City, 523900, Guangdong Province, China. hang1193@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Haiping</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Binhaiwan Central Hospital of Dongguan, Dongguan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yanbing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Binhaiwan Central Hospital of Dongguan, Dongguan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biotechnol Lett</MedlineTA><NlmUniqueID>8008051</NlmUniqueID><ISSNLinking>0141-5492</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C544749">MIRN103 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C549045">MIRN107 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C106644">SOCS3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494086">STAT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071223">Suppressor of Cytokine Signaling 3 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071223" MajorTopicYN="N">Suppressor of Cytokine Signaling 3 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">MiR-103</Keyword><Keyword MajorTopicYN="N">MiR-107</Keyword><Keyword MajorTopicYN="N">SOCS3</Keyword><Keyword MajorTopicYN="N">STAT3 phosphorylation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33796959</ArticleId><ArticleId IdType="doi">10.1007/s10529-021-03115-z</ArticleId><ArticleId IdType="pii">10.1007/s10529-021-03115-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. eLife. https://doi.org/10.7554/eLife.05005</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.05005</ArticleId><ArticleId IdType="pubmed">26274565</ArticleId><ArticleId IdType="pmc">4566075</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2(6):410&#x2013;416</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardekani AM, Naeini MM (2010) The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2(4):161</Citation><ArticleIdList><ArticleId IdType="pubmed">23407304</ArticleId><ArticleId IdType="pmc">3558168</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang PC, Chen SC, Chen KT (2016) The current status of the disease caused by enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health 13(9):890</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph13090890</ArticleId></ArticleIdList></Reference><Reference><Citation>Chea S et al (2015) Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis. https://doi.org/10.3201/eid2101.140992</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2101.140992</ArticleId><ArticleId IdType="pubmed">26290955</ArticleId><ArticleId IdType="pmc">4550143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L et al (2016) MicroRNA-223 promotes type I interferon production in antiviral innate immunity by targeting forkhead box protein O3 (FOXO3). J Biol Chem 291(28):14706&#x2013;14716</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.700252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HY et al (2019) miR-103/107 prolong Wnt/&#x3b2;-catenin signaling and colorectal cancer stemness by targeting Axin2. Sci Rep 9(1):9687</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41053-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmiest D et al (2016) Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex. Nat Commun 7:13476</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13476</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng B et al (2016) MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1&#x3b2;. Life Sci 147:117&#x2013;124</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2016.01.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham GA, Williams JJL, Nasim MT, Palmer TM (2019) Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol Sci 40(5):298&#x2013;308</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Felekkis K, Touvana E, Stefanou C, Deltas C (2010) microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14(4):236</Citation><ArticleIdList><ArticleId IdType="pubmed">21311629</ArticleId><ArticleId IdType="pmc">3031315</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng N et al (2017) Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res 237:27&#x2013;36</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.05.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster SC, Tate MD, Hertzog PJ (2015) MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Front Immunol 6:334</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00334</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Hou M, Liu X, Li Z, Yang Y, Zhang W (2020) Induction of SOCS expression by EV71 infection promotes EV71 replication. Biomed Res Int 2020:2430640</Citation><ArticleIdList><ArticleId IdType="pubmed">32149091</ArticleId><ArticleId IdType="pmc">7054758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC et al (2014) Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun 5:3344</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4344</ArticleId></ArticleIdList></Reference><Reference><Citation>Killip MJ, Fodor E, Randall RE (2015) Influenza virus activation of the interferon system. Virus Res 209:11&#x2013;22</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeberlein B et al (2010) Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 148(1&#x2013;2):51&#x2013;59</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y et al (2014) A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes 48(2):260&#x2013;272</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1035-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahony R, Ahmed S, Diskin C, Stevenson NJ (2016) SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci 73(17):3323&#x2013;3336</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2234-x</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O&#x2019;Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87&#x2013;103</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RC et al (2011) HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J Immunol 41(4):1058&#x2013;1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201041198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NV, Tran JT, Sanchez DJ (2018) HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation. Innate Immun 24(8):490&#x2013;500</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425918803674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Wong KT (2015) Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathol 25(5):614&#x2013;624</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12279</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli EK et al (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4(11):e1000196</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000196</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Hertzog PJ (2015) Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol 36(3):150&#x2013;160</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.02.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Raftery N, Stevenson NJ (2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway. Cell Mol Life Sci 74(14):2525&#x2013;2535</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2520-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A (2019) An update on enterovirus 71 infection and interferon type I response. Rev Med Virol 29(1):e2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId></ArticleIdList></Reference><Reference><Citation>Saguil A, Kane SF, Lauters R, Mercado MG (2019) Hand-foot-and-mouth disease: rapid evidence review. Am Fam Phys 100(7):408&#x2013;414</Citation></Reference><Reference><Citation>Schreiber G, Piehler J (2015) The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 36(3):139&#x2013;149</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.01.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanic M (1963) A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathol Microbiol (Basel) 26:298&#x2013;302</Citation></Reference><Reference><Citation>Stifter SA, Feng CG (2015) Interfering with immunity: detrimental role of type I IFNs during infection. J Immunol 194(6):2455&#x2013;2465</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402794</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM (2015) Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol 89(8):4143&#x2013;4157</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03101-14</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlotides G et al (2004) SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 320(3):1007&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.06.051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JX et al (2015) MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ Res 117(4):352&#x2013;363</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.305781</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LJ et al (2014) Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE 9(4):e95272</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095272</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Wang X, Gao H, Chen B, Si C, Wang S (2020) Downregulation of miR-155-5p facilitates enterovirus 71 replication through suppression of type I IFN response by targeting FOXO3/IRF7 pathway. Cell Cycle 19(2):179&#x2013;192</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2019.1704512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K et al (2017) MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B. Biochem Biophys Res Commun 488(4):628&#x2013;633</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.03.109</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu QF et al (2018) MiR-103/107 induces tumorigenicity in bladder cancer cell by suppressing PTEN. Eur Rev Med Pharmacol Sci 22(24):8616&#x2013;8623</Citation><ArticleIdList><ArticleId IdType="pubmed">30575901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z et al (2013) Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 87(10):5645&#x2013;5656</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02655-12</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Qi Y, Fan H, Cui L, Shi Z (2016) Systematic identification and bioinformatic analysis of MicroRNAs in response to infections of coxsackievirus A16 and enterovirus 71. Biomed Res Int 2016:4302470</Citation><ArticleIdList><ArticleId IdType="pubmed">27843944</ArticleId><ArticleId IdType="pmc">5098103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>